|
|
| Publications |
|
1.
Alves
CM, Reis CM, Hunt JA. (2003). Preliminary study on human protein
adsorption and leukocyte adhesion to starch based biomaterials. J. Materials Science: Materials in Medicine.
14, 157-165. 2.
Baldwin,
L, Flanagan, BF, McLaughlin, PJ, Parkinson, RW, Hunt, JA and Williams, DF. (2002).
A study of interface membranes from revision accord knee arthroplasty:
the role of T lymphocytes. Biomaterials
23, 3007-3014. 3.
Baldock
C, Gilpin C, Koster A, Ziese U, Kadler KE, Kielty CM, Holmes DF. (2002).
Three-dimensional reconstructions of extracellular matrix polymers using
automated electron tomography.
J.Struct. Biol. 138, 130-135. 4.
Baldock
C, Sherratt MJ, Shuttleworth CA & Kielty CM. (2003). The
supramolecular organisation of collagen VI microfibrils. J.Mol.Biol. 330, 297-307 5.
Ball
SG, Bella J, Kielty CM & Shuttleworth CA. (2003). Structural basis of type VI collagen dimer formation. J.Biol.Chem. 278, 15326-15332. 6.
*Ball
SG. (2003). What is a stem cell. Biol.Sci.Rev.
16, 21-23 7.
Ball
SG, & Kielty CM (2004). Bone marrow
mesenchymal stem cell differentiation into smooth muscle cells: roles of PDGF a
receptor signaling and VEGF in SM a-actin filament organization. (submitted). 8.
Ball
SG, Shuttleworth CA & Kielty CM (2004).
Role of direct cell contact in mesenchymal stem cell fate. Int.J.Biochem.Cell Biiol. 36, 714-727. 9.
Bax
DV, Bernard SE, Lomas A, Morgan A, Shuttleworth CA, Humphries MJ & Kielty
CM.(2003). Cell adhesion to fibrillin-1
molecules and microfibrils is mediated by α5β1 and αvβ3
integrins. J.Biol.Chem 278,
34605-34616. 10.
Bayat
A., Bock O., Mrowietz U., Ollier W.E.R., Ferguson M.W.J. (2003) Genetic
susceptibility in keloid disease and hypertrophic scarring Transforming growth
factor beta one (TGFb1) common polymorphisms and plasma levels in keloid
disease and hypertrophic scarring".
Plastic and Reconstructive Surgery, 111, 535-546. 11.
Bayat,
A., Walter, J.M., Lamb, H., Ferguson, M.W.J., Ollier, W.E.R.(2003) Rapid
denaturing high performance liquid chromatography (DHPLC) for mutation
screening of the transforming growth factor β3 gene using a novel proof
reading polymerase. European Journal of Immunogenetics, 30, 1-6. 12.
*Bayat
A., McGrouther D.A., Ferguson M.W.J. (2003) Skin scarring. British Medical Journal, 326, 88-92. 13.
Bayat,
A., Watson, J.S., Stanley, J.K., Ferguson, M.W.J., Ollier, W.E.R. (2003)
Genetic susceptibility to Dupuytren's disease: association of Zf9 transcription
factor gene. 14.
Plastic
and Reconstructive Surgery;111:2133-21399. 15.
Bayat
A, Stanley JK, Watson JS, Ferguson MW, Ollier WE.(2003) Genetic susceptibility
to Dupuytren's disease: transforming growth factor beta receptor (TGFbetaR)
gene polymorphisms and Dupuytren's disease. British Journal of Plastic Surgery.
56:328-334. 16.
Bayat
A, Ollier WER, Ferguson MWJ and McGrouther DA.
(2003). “Aggressive Keloid”: a
severe variant of familial keloid scarring.
J R Soc Med, 96, 554-555. 17.
Beare
AH, O'Kane S, Krane SM and Ferguson MWJ. (2003) Severely impaired wound healing
in the collagenase-resistant mouse. J Invest Dermatol.120(1):153-63. 18.
Bennett
WR, Crew TE, Slack JM, Ward A. (2003) Structural-proliferative units and organ
growth: effects of insulin-like growth factor 2 on the growth of colon and
skin. Development. 130(6):1079-88 19.
Bernacca, G.M., O’Connor, B., Williams D.F., Wheatley,
D.J. Hydrodynamics function of polyurethane prosthetic heart valves: influences
of Young’s modulus and leaflet thickness, Biomaterials, 2002, 23, 45-50. 20.
Bloor
DJ, Metcalfe AD, Rutherford A, Brison DR, Kimber SJ. (2002) Expression of cell
adhesion molecules during human preimplantation embryo development. Mol Hum
Reprod. 8(3):237-45. 21.
*Brison
DR, Metcalfe AD, Bloor DJ, Hunter HR, Brady G, Kimber SJ. (2003).
Analysis of apoptosis in the preimplantation embryo. In: A Laboratory Guide of the
Preimplantation Mouse Embryo. (Gardner DK, Lane M, Watson AJ, eds). In press. 22.
Buckley
KA, Golding SL, Rice JM, Dillon JP, Gallagher JA (2003). Release and interconversion of P2 receptor
agonists by human osteoblast-like cells.
FASEB J. 17, 1401-1410 23.
Bujan
J, Gimeno MJ, Jimenez JA, Kielty CM, Mecham RP, Bellon JM. (2003).
Expression of elastic components in healthy and varicose veins. World J.Surg. 27, 901-905. 24.
Cain
S, Rock MJ, Freeman L, Baldock C, Morgan A, Mellody K, Sherratt MJ, Marson A,
Shuttleworth CA, Weiss AS, Kielty CM.
(2003). Molecular basis of
elastic fibre formation: critical interactions and a tropoelastin – fibrillin
-1- crosslink. EMBO J (submitted). 25.
Cain
S, Rock MJ, Mellody K, Freeman L, Marson A, Baldock C, Shuttleowrth CA &
Kielty CM (2004). Mass spectrometry
analysis of fibrillin microfibril composition and organization. J.Mol.Biol (in review). 26.
Callaghan
JT, Hunt JA, Sutcliffe CJ, Morgan RH, Halford B, Black RA. (2003). Bone growth model for the assessment
of implant surface topology.
Biomaterials (submitted). 27.
Canfield
AE, Farrington C, Dziobon MD, Boot-Handford RP, Heagerty AM, Kumar SN, Roberts
ISD. (2002). The involvement of matrix glycoproteins in vascular calcification
and fibrosis: an immunohistochemical study.
J.Path. 196, 228-234. 28.
Charalambous
M, Smith FM, Bennett WR, et.al. (2003).
Disruption of the imprinted Grb10 gene leads to disproportionate overgrowth by
an Igf2-independent mechanism.
Proceedings of the National Academy of Sciences (USA). 100, 14, 8292-8297. 29.
Collett
G, Wood A, Alexander MY, Varnum BC, Boot-Handford RP, Ohanian V, Ohanian J,
Fridell YW, Canfield AE. (2003). Receptor tyrosine kinase Axl regulates the
osteogenic differentiation of pericytes.
Circ.Res. 92, 1123-1129. 30.
Crew
T, Bennett B, Kelly S. et.al. (2003)
Combined effects of insulin-like growth factor 2 excess and tumour
suppressor loss in overgrowth and cancer,
Genetical Research, 81, 3, 237. 31.
Curran
SJ, Black RA. (2001). Mass Transport and Hydrodynamic Modelling
for an Annular Flow Bioreactor.
Advances in Bioengineering, ASME BED-Vol.51. 32.
*Curran
SJ, Black RA. (2003). Taylor Vortex
Bioreactors for Enhanced Mass Transport, in Tissue Engineering Bioreactors
Principles, Design and Operation, Al-Rubeai M, Chaudhuri JB (Eds), Kluwer
Academic Publishers (in press). 33.
Curran
SJ, Black RA. (2003). Quantitative experimental study of shear
stresses and mixing in progressive flow regimes within annular-flow
bioreactors. Chem.Eng.Sci (In Press). 34.
Diagne
I, Hall SM, Kogake S, Kielty CM, Haworth SG.
(2003). Paxillin associated
focal adhesion involvement in perinatal pulmonary arterial remodelling. Matrix Biol. 22, 193-205. 35.
Farrington
Rock C, Crofts NJ, Doherty MJ, Ashton BA, Griffin-Jones C, Canfield AE. (2003).
Chondrogenic and adipogenic potential of microvascular pericytes. Circulation, (submitted). 36.
Feugier
P, Black RA, Hunt JA and How TV (in press). Attachment, morphology and
adherence of human endothelial cells to vascular prosthesis materials under the
action of shear stress. Biomaterials. 37.
*Fisher,
RK, How, TV, Black, RA and Harris, PL.
Experimental evaluation of the haemodynamics of peripheral arterial
bypass grafts. In: Vascular Grafts:
Experiment and Modelling, Andrea Tura (Ed) WIT Press, 2003, 151-191. 38.
Flasza
M, Gorman P, Roylance R, Canfield AE, Baron M.
(2002). Alternative splicing
determines the domain structure of WWP1, a Nedd4 family protein. Biochem Biophys Res Commun, 290, 431-437. 39.
Freemont AJ, Watkins A, Le Maitre C, Jeziorska M, Hoyland
JA. (2002).
Current understanding of cellular and molecular events in intervertebral
disc degeneration: implications for therapy. J Pathol. 196, 374-9. 40.
Freemont,
AJ, Jeziorska, M, Hoyland, JA, Rooney, P, Kumar, S. (2002). Mast cells in the pathogenesis of chronic
back pain: a hypothesis. J.Pathol. 197,
281-5 41.
Freemont,
AJ, Watkins, A, Le Maitre, C, Baird, P, Jeziorska, M, Knight, MTN, Ross, ERS,
O’Brien, JP, Hoyland, JA. (2002). Nerve growth factor expression and
innervation of the painful intervertebral disc. J Pathol. 197, 286-92 42.
Ghosh
J, Murphy M, Turner N, Khwaja N, Halka A, Kielty CM & Walker MG. (2004).
The role of transforming growth factor beta in the vascular system. J.Vasc.Surg. (submitted). 43.
Ghosh
J, Walker MG & Kielty CM (2004).
The influence of fluid shear forces on human coronary artery smooth
muscle cells. (submitted to Circulation
Research). 44.
Goodstone
NJ, Hardingham TE (2002) Tumour necrosis factor alpha is a more potent inducer
of nitric oxide synthase than interleukin-1 beta in porcine articular chondrocytes.
Rheumatology 41, 883-891 45.
Hardingham
T, Tew S, Murdoch A (2002) Tissue Engineering: Chondrocytes and Cartilage.
Arthritis Research 4 (suppl 3), 63-68 46.
*Hardingham
T, Heng BC, Gribbon P (2002) Analysis of the concentrated solution properties
of hyaluronan by confocal-FRAP show no evidence of chain-chain association.
Hyaluronan, Vol 1, Chemistry, Biochemistry and Cell Biology, Eds JF Kennedy, GO
Phillips, PA Williams and V Hascall, Woodhead, Cambridge, UK, 2002, pp 123-126 47.
*Hardingham
TE. (2003). UK Centre for Tissue Engineering. Bioventure, Vol.3, 16-19. 48.
*Hardingham
TE. (2003). Regional Perspectives on Tissue Engineering: View from a Small
Island. Tissue Engineering, 9,
1063-1064. 49.
*Hardingham
TE, Kielty CM, Canfield AE.
(2004). Cell Culture in Tissue
Engineering. (Stacey G. Ed.). Wiley (in press). 50.
Hundal
K, Watkins A, Le Maitre CL, Freemont AJ, Hoyland JA (2002). Chondrocyte senescence in intervertebral
disc degeneration. Journal of
Pathology, 198, 51A-51A. 51.
Haston
JL, Engelsen SB, Roessle M, Clarkson J, Blanch EW, Baldock C, Kielty CM, Wess
TJ. (2002). Raman spectroscopy and X-ray diffraction: a combined study of
fibrillin-rich microfibrillar elasticity.
J.Biol.Chem. 278, 41189-41197. 52.
*Hunt
JA. Encyclopaedia of Materials: Science
and Technology. Editor: DF
Williams. Chapter: Inflammation . Pergamon Press, Elsevier Science,
Amsterdam. 4068-4075. 2001. 53.
*Hunt
JA. (2003). Encyclopaedia of Biomaterials and Biomedical Engineering. Editors: GE Wnek and GL Bowlin. Chapter: Foreign Body Response. Marcel Dekker, New York. In press. 54.
*Hunt
JA. (2003). Biopolymer Methods in Tissue Engineering. Editors: P Hatton and A Hollander. Cell Attachment Assays. The Humana Press Inc. Totowa. In press. 55.
*Hunt
JA and Shoicet MS (2001). Biomaterials:
surface interactions. Current Opinion
in Solid State & Materials Science, Vol. 5, Issues 2-3, 161-162. 56.
*Hunt,
JA, and Shoichet, MS. (2002). Biomaterials: drug delivery systems, Current
Opinion in Solid State & Materials Science, 6, 281. 57.
*Kielty
CM, Sherratt MJ, Shuttleworth CA.
(2002). Elastic fibres. J.Cell Sci. 115, 2817-2828. 58.
*Kielty
CM and Grant ME. (2002). The collagen
family: structure, assembly and organisation in the extracellular matrix. In ‘Connective Tissue and its Heritable
Diseases; Molecular, Genetic and
Medical Aspects’ (Royce PM and
Steinmann B. Eds.). Wiley-Liss, New
York, p159-221. 59.
*Kielty
CM. (2003). Fibrillin: from microfibril
assembly to biomechanical function.
Chapter in ‘Elastomeric Proteins’ (Shewry P and Bailey AJ. Eds.). Royal Society Discussion Meeting. Cambridge University Press (in press). 60.
*Kielty
CM, Sherratt MJ, Haston JL, Wess TJ, Shuttleworth CA. (2003). Fibrillin-rich
microfibrils: elastic biopolymers of the extracellular matrix. J. Muscle Research and Cell Motility.
(invited chapter). 23, 581-596. 61.
*Kielty
CM, Wess TJ, Haston JL, Sherratt MJ, Baldock C, Shuttleworth CA. (2004).
Organisation and biomechanical properties of fibrillin microfibrils. In ‘Marfan Syndrome’, Landes
Bioscience/Eurekah.com (in press). 62.
*Kielty
CM, Bax DV, Hodson N, Sherratt MJ. (2004).
Elastic fibre molecules in vascular tissue engineering. In ‘Surfaces and Interfaces in Biomaterials’
(Vadgama P, Ed.). Woodhead Publishing
Ltd. (in press). 63.
Kielty
CM. Guest Editor, Directed Stem Cell
Issue, Int.J.Biochem.Cell Biol. April,
2004 64.
Kielty
CM, Baldock C, Rock MJ, Ashworth JL, Shuttleworth CA. (2002). Fibrillin: from microfibril assembly to
biomechanical function.
Phil.Trans.R.Soc.Lond. B 357, 207-217. 65.
Kolettas
E, Muir HI, Barrett JC, Hardingham TE.
(2001). Chondrocyte phenotype
and survival are regulated by culture conditions and by specific cytokines
through the expression of SOX9.
Rheumatology, 40, 1146-1156. 66.
Le
Maitre CL, Rajpura A, Staley W, Byers RJ, Ross R, Knight M, Freemont AJ,
Hoyland JA. (2001). In Vitro gene transfer to human
intervertebral disc chondrocytes by an adenovirus vector. Journal of Pathology, 193, 1A-1A. 67.
Le
Maitre CL, Baird P, Williamson B, Ross R, Freemont AJ, Hoyland JA. (2003).
Expression of the IL-1 family in human intervertebral disc. J.Pathol. 201: 56A-56A Suppl. 68.
Le
Maitre CL, Williamson B, Ross R, Freemont AJ, Hoyland JA. (2003).
Response of human intervertebral disc cells to IL-1. J.Pathol.
201: 56A-56A Suppl. 69.
Le Maitre CL, Hoyland JA, Freemont AJ. (2004) Studies of human Intervertebral
Disc Cell function in a constrained in vitro tissue culture system. Spine, 29, 1187-1195. 70.
Le
Maitre CL, Richardson SMA, Baird P, Williamson B, Ross R, Freemont AJ, Hoyland
JA. (2003). IL-1: Role in Degeneration of the Intervertebral Disc and its
inhibition using IL-Ra gene transfer.
Molecular Therapy, 7(5): S405-S405. 71.
Le
Maitre CL, Freemont AJ, Hoyland JA. (2004).
Localisation of degradative enzymes and their inhibitors in the
degenerate human intervertebral disc. J
Pathol 204, 47-54. 72.
Le
Maitre CL, Rothwell NJ, Freemont AJ, Hoyland JA (2004). Ex vivo gene therapy for disc
degeneration. J Pathol 204, 12A-12A
Suppl. 73.
Li
Y, Tew SR, Russell AM, Gonzalez K, Hardingham TE, Hawkins RE. Transduction of human articular chondrocytes
with adenoviral, retroviral and lentiviral vectors and the effects of enhanced
expression of SOX9. Tissue
Engineering (In press). 74.
Markkula,
TK, Hunt, JA, Pu, FR, and Williams, RL.
(2002). Surface Chemical
Derivatisation of Plasma Treated PET and PTFE. Surface and Interface Analysis
(SIA), 34, 583-58. 75.
Marques,
AP, Reis, RL, and Hunt, JA.
(2002). The biocompatibility of
novel starch based polymers and composites: in vitro studies. Biomaterials. 23,
1471-1478. 76.
Marson
A, Rock MJ, Cain S, Baldock C, Shuttleworth CA & Kielty CM. (2004).
Molecular basis of fibrillin-1 assembly. (submitted to J.Biol.Chem.). 77.
Metcalfe
AD, Bloor DJ, Lieberman BA, Kimber SJ and Brison DR. (2003) Amplification of
representative cDNA pools from single human oocytes and pronucleate embryos.
Mol Reprod Dev. 65(1):1-8. 78.
Metcalfe
AD, Hunter HR, Bloor DJ, Liberman BA, Picton HM, Leese HJ, Kimber SJ and Brison
DJ. (2004). Expression of 11 members of the BCL2 family of apoptosis
regulatory molecules during human preimplantation embryo development and
fragmentation. Molecular Reproduction
and Development, (In press). 79.
Michanetzis,
GPA, Missirlis, YF, Rhodes, NP, Williams, DF, Eloy, R and Lemm, W. (2002).
Influence of test protocol in determining the blood response to model
polymers. Journal of Materials Science:
Materials in Medicine, 12, 757-765. 80.
Pu
FR, Williams RL, Markkula T and Hunt JA (2001). Monocyte adhesion and adhesion molecule expression on human
endothelial cells on plasma treated PET and PTFE in vitro. Materials in Medicine, 12, 971-977. 81.
Pu,
FR, Williams, RL, Markkula, T, and Hunt
JA. (2002). Expression of Leukocyte-Endothelial Cell Adhesion Molecules on
Monocyte Adhesion to Human Endothelial Cells on Plasma Treated PET and PTFE in
vitro. Biomaterials 23, 4705-4718. 82.
Pu,
FR, Williams, RL, Markkula, T. and Hunt
JA. (2002). Effect of plasma treated PET and PTFE on expression of adhesion
molecules by human endothelial cells in vitro.
Biomaterials 23, 2411-2428. 83.
Rajnoch
C, Ferguson S, Metcalfe AD, Herrick SE, Willis HS and Ferguson MWJ. (2003)
Regeneration of the ear following wounding in different mouse strains is
dependent on the severity of wound trauma. Dev Dyn. 226(2):388-97. 84.
Rhodes
NP, Srivastava JC, Longinotti C, Smith RF.
Heterogeneity in proliferative potential of ovine mesenchymal stem cell
colonies. Journal of Materials Science:
Materials in Medicine. In press. 85.
Rhodes
NP, Srivastava JC, Longinotti C, and Smith RF.
Metabolic and histological analysis of mesenchymal stem cells grown in
3-dimensional hyaluronan-based scaffolds.
Journal of Materials Science: Materials in Medicine. In press. 86.
Rice
JM, Hunt JA, Gallagher JA. Quantitative
evaluation of the biocompatible and osteogenic properties of a range of biphasic
calcium phosphate (BCP) granules using primary cultures of human osteoblasts
and monocytes. (2003). Calcified Tissue
International, 72, 726-736. 87.
Rice
JM, Hunt JA, Gallagher JA, Hanarp P, Sutherland DS, Gold J. (2003).
Quantitative assessment of the response of primary derived human
osteoblasts and macrophages to a range of nanotopography surfaces in a single
culture model in vitro. Biomaterials,
24, 4799-4818 88.
Rice
JM, Hunt JA, Gallagher JA. The response
of primary human osteoblast/macrophage co-culture models to a range of Biphasic
Calcium Phosphate granules with varying proportions of Tricalcium Phosphate in
vitro. Accepted Biomaterials 2003. 89.
Richardson,
S, Le Maitre CL, Kielty C, Freemont AJ, Hoyland JA (2004). Human bone marrow stromal cells as a source
of cells for engineering human intervertebral disc. J Pathol 204, 5A-5A Suppl. 90.
Rock
MJ, Cain S, Freeman L, Baldock C, Morgan A, Mellody K, Sherratt MJ, Marson A,
Shuttleworth CA, Weiss AS & Kielty CM.
(2004). Molecular basis of
elastic fibre formation: critical interactions and a tropoelastin –
fibrilin-1-crosslink. J.Biol.Chem. 279,
23748-23758 91.
Sherratt
MJ, Holmes DF, Haston JL, Wess TJ, Shuttleworth CA & Kielty CM.
(2003), Fibrillin microfibrils are
stiff reinforcing fibres in compliant tissues.
J.Mol.Biol. 332, 183-193. 92.
Sherratt
MJ, Holmes DF, Shuttleworth CA, Kielty CM.
(2004). Substrate dependent
morphology of supra-molecular assemblies: fibrillin and type VI collagen
microfibrils. Biophys J, 86, 3211-3222.
93.
Sherratt
MJ, Lu J & Kielty CM. (2004). Biomaterials surface chemistry influences
fibrillin microfibril morphology. (submitted to Biophys. J.). 94.
Sinha
S, Shuttleworth CA, Heagerty AM, Kielty CM.
(2002). Expression of latent
TGFbeta binding proteins and association with TGFbeta-1 and fibrillin-1 in the
response to arterial injury.
Cardiovasc. Res. 53, 971-983. 95.
Sive
JI, Baird P, Le Maitre CL, Hoyland JA, Freemont AJ. (2001). Investigation
into the chondrocytic phenotype and pattern of aggrecan distribution in cells
of the normal and degenerate intervertebral disc. Journal of Pathology 195: 37A-37A. 96.
Sive,
JI, Baird, P, Jeziorska, M, Watkins, A, Hoyland, JA, Freemont, AJ (2002).
Expression of chondrocyte markers by cells of normal and degenerate
intervertebral discs. Mol Pathol, 55, 91-97 97.
Stephan
S, Shuttleworth CA, & Kielty CM.
Expression and supramolecular assembly of recombinant α2(VIII)
collagen homotrimers. J. Biol. Chem. 279, 21469-21477. 98.
Swindle,
EJ, Hunt, JA, Coleman, JW. (2002). A comparison of reactive oxygen species
generation by rat peritoneal macrophages and mast cells using the highly
sensitive real-time chemiluminescent probe Pholasin; inhibition of
antigen-induced mast cell degranulation by macrophage-derived hydrogen
peroxide. Journal of Immunology, 169, 5866-5873. 99.
Tang
ZG, Black RA, Curran JM, Hunt JA, Rhodes NP, Williams DF. (2003). Surface properties and biocompatibility of
solvent cast poly (e-caprolactone) films. Biomaterials,
25, 4741-4748 100.
Turner
NJ, Kielty CM, Walker MG, Canfield AE.
(2003). A novel hyaluronan
biomaterial (Hyaff-11®) as a scaffold for endothelial cells in
tissue engineered vascular grafts.
Biomaterials (in press). 101.
Valentijn
AJ, Metcalfe AD, Kott J, Streuli CH and Gilmore AP. (2003) Spatial and temporal
changes in Bax subcellular localization during anoikis. J Cell
Biol.;162(4):599-612. 102.
Vallabhaneni
SR, Gilling-Smith GL, Brennan JA, Heyes RR, Hunt JA, How TV, Harris PL. (2003).
Can monitoring of intrasac pressure accurately predict failure of endovascular
aneurysm? Journal of Endovascular
Therapy. 10:524-530. 103.
*Williams,
DF. (2002). The enabling technological advantages of chitin. Medical Device
Technology, 13(1), 8-12. 104.
*Williams,
DF. (2002). Catheters, materials and
infections. Medical Device Technology,
13(2), 8-11. 105.
*Williams,
DF. (2002). Medical nanotechnology: how
small can we go? Medical Device
Technology, 13(3), 7-9. 106.
*Williams,
DF. (2002). To test or not to test: the
value of biological safety testing.
Medical Device Technology, 13(4), 8-10. 107.
*Williams,
DF. (2002). The philosophy, nature and
nomenclature of tissue engineering and biomimetics. Min. Invas. Ther & Allied Techno. 11, 87-92. 108.
*Williams,
DF. (2002). New metals for old, Part 1: Benefits and Concerns. Medical
Device Technology, 13(6), 11-13. 109.
*Williams,
DF. (2002). New metals for old, Part 2:
Real and imaginary properties. Medical
Device Technology, 13(7), 7-9. 110.
*Williams,
DF. (2002). Public confidence in
medical technology. Medical Device
Technology, 13(10), 11-13. 111.
*Williams,
DF. The inert – bioactivity conundrum.
In Ellingsen, J-E. (Ed.) The
Implant Tissue Interface. CRC Press,
Boca Raton, (In Press). 112.
Williams
D.F. Perspectives on the contributions of biomaterials and tissue engineering
to bone repair, reconstruction and regeneration, In Bone Engineering, (ed)
J.E.Davies, Em squared Incorporated, Toronto, 2001, 577-584. 113.
Williams
D.F. Reconstructing the body, costs, prices and risks. The Geneva Papers on Risk and Insurance,
2003, 28 (2), 331-338. 114.
*Williams D.F. The Japanese Approach to Tissue
Engineering, The Royal Academy of Engineering, 2003. 115.
*Williams,
DF. Reassessing bioactive
surfaces. Medical Devices Technology
(In Press). 116.
Williams,
DF. Biomaterials and tissue engineering in reconstructive surgery. In Sadhana
Special Issue. 2003, 28, 563-574. 117.
Williams
RL, Wilson DJ and Rhodes NP. Stability
of plasma treated silicone rubber and its influence on blood
compatibility. Biomaterials. In press.
118.
Wilson
DJ, Rhodes NP, Williams RL. Surface
modification of a segmented polyetherurethane using a low powered gas plasma
and its influence on the activation of the coagulation system. Biomaterials, 24, 5069-5081 Conference Abstracts 1.
Alves,
CM, Reis, RL, Hunt, JA. (2002). Evaluation of Human Protein Adsorption onto
Starch Based Biodegradable Materials: from Unitary to Complex Competitive
Systems. 17th European
Society for Biomaterials. Barcelona,
September. 2.
Andrews
KD, Black RA, Hunt JA and How TV.
(2001). Electrostatic spinning
for Tissue Engineering applications.
Proceedings of the ESB Congress, London 11th-15th
September. 3.
Andrews
KD, Black RA, Hunt JA (2003). Cellular
responses induced by electrostatically spun tissue engineering scaffolds. 18th European Society for
Biomaterials. Stuttgart, October. 4.
Baldwin
L, Flanagan BF, McLaughlin PJ, Parkinson RW, Darby A, Hunt JA. (2001).
The Role of T Lymphocytes in the failure of Total Knee
Arthroplasty. ESB, London 12th-14th
September. 5.
Baldwin,
L, Flanagan, BF, McLaughlin, Parkinson, RW, and Hunt JA. (2002). Synovial Fluid Cytokines in Revision Knee
Arthroplasty. 17th European
Society for Biomaterials. Barcelona,
September. 6.
Baldwin
L, Rice JM, Hunt JA (2003). The effect
of inflammatory cytokines on mesenchymal stem cell differentiation for tissue
engineering applications. 18th
European Conference on Biomaterials.
Stuttgart, October. 7.
Baldock
C, Sherratt MJ, Shuttleworth CA and Kielty CM (2001). Biomechanical properties of fibrillin-rich microfibrils. Royal Soc. Meeting on Elastomeric Proteins. 8.
Baldock
C, Sherratt MJ, Shuttleworth CA and Kielty CM.
(2003). Structural analysis of
collagen VI microfibrils. BSMB, Oxford,
UK. March/April. 9.
Ball
SG, Bella J, Kielty CM and Shuttleworth CA.
(2002). Role of MIDAS sequences
in intracellular collagen VI assembly.
Abstract and poster at Federation of European Connective Tissue
Societies (FECTS) Meeting, Brighton, UK.
July 10.
Barley
C, Shuttleworth CA and Kielty CM.
(2003). The role of LTBP-3 in
endochondral bone formation. BSMB,
Oxford, UK. March/April. 11.
Beare
AHM and Ferguson MWJ. (2003). Severely impaired wound healing in the
collagenase resistant mouse. Gordon
Research Conference, Barga, Italy. 12.
Beare
AHM and Ferguson MWJ (2003). Severely
impaired wound healing in the collagenase resistant mouse. European Tissue Repair Society Meeting,
Amsterdam. 13.
Bernard,
S, Morgan, A, & Kielty, CM (2002) Integrin-mediated cell attachment to
intact fibrillin-rich microfibrils. Keystone symposium, Colorado, USA.
February. 14.
Bernard,
SE, Lomas, A, Shuttleworth, CA & Kielty, CM (2002) Fibrillin-rich
microfibrils as a ligand for dermal and vascular cells: adhesion, spreading and
cellular consequences. Abstract (and talk) at Elastin 2002 Symposium, Italy,
July. 15.
Black
RA, Curran SJ. (2003). Improving mass transport in bioreactors for
in vitro cartilage expansion and Tissue Engineering, Tissue Engineering of the
Synovial Joint Components, Leeds 28th Annual Biomaterials Meeting,
11th January. 16.
Bluff
J, Ireland G and Ferguson MWJ.
(2003). The development and
functionality of the cutaneous vasculature in murine incisional wounds. Gordon Research Conference, Barga, Italy. 17.
Cain
S, Morgan A, Shuttleworth CA and Kielty CM.
(2003). Mass spectrometry
analysis of isolated fibrillin-rich microfibrils. Gordon Research Conference ‘Elastin and Elastic Fibres’, August. 18.
Callaghan,
JT, Hunt, JA, Sutcliffe, CJ, Morgan, RH, Halford, B and Black, RA. (2002).
Effect of CoCr Implant Macrostructure and Chemistry on Bone Growth in
vitro. 17th European Society
for Biomaterials. Barcelona, September. 19.
Charalambous
M, Bennett WR, Smieth F. et.al.
(2003). Growth regulation by
Grb10. Genetical Research 81, 3, 236-236. 20.
Chen
R, Hunt JA, Williams DF (2003).
Immobilised RGD peptides on silane-modified PLLA surface, ETES, September. 21.
Chen
R, Hunt JA, Williams DF. (2003). PLLA surface modified with RGD containing
peptides. TESi, Orlando, USA, December. 22.
Crouchley,
C & Kielty, CM (2002) Isolation of adult human vascular stem cells.
Abstract and poster at Federation of European Connective Tissue Societies
(FECTS) meeting, Brighton July. 23.
Crouchley,
CM, Ball, SG, Shuttleworth, CA & Kielty, CM (2003) Isolation of adult human
vascular progenitor cells. BSMB, Oxford March/April. 24.
Curran,
SJ, and Black, RA. (2002). Shear stress effects on freely suspended
cells in an annular flow bioreactor.
Proceedings 17th European Society for Biomaterials
Conference. Barcelona, Spain, 11th-14th
September. 25.
Curran
SJ and Black RA. (2002). Mass transport in an annular flow bioreactor
for cell culture under dynamic mixing conditions. Proceedings 17th European Society for Biomaterials
Conference. Barcelona, Spain, 11th-14th
September. 26.
Curran,
SJ, Rice, JM, Chen, R. Hunt, JA, Rhodes, NP, Williams, DF, and Black, RA. (2003).
Fluid Dynamics, Oxygen Transport and Cell Seeding Capabilities of
Annular Flow Bioreactors for Tissue Engineering Applications. 29th Annual Meeting of the
Society For Biomaterials, Reno, Nevada, USA.. 30th April-3rd
May. 27.
Curran
SJ, Rice JM, Chen R, Donegan G, Williams DF, Hunt JA, Black RA. (2003). Cell-seeding and proliferation on the lumina
of PLLA tubules in a dynamic Couette-Taylor Bioreactor. 2nd European Tissue Engineering
Society Meeting, Genoa, Italy, 1st-4th September. 28.
Curran
SJ, Rice JM, Chen R, Donegan G, Williams DF, Hunt JA, Black RA. (2003).
Cell-seeding and expansion on the lumina of PLLA tubules in a novel
2-step dynamic bioreactor. 18th
European Society for Biomaterials.
Stuttgart, October. 29.
Curran
SJ, Chen R, Rice JM, Hunt JA, Williams DF, Black RA. (2003). Novel bioreactor
system for luminal cell-seeding and fluid mechanical stimulation of PLLA
tubules. TESi Annual Meeting, Orlando,
FL, USA. December.. 30.
Curran
SJ, Rice JM, Chen R, Donegan G, Williams DF, Hunt JA, Black RA. (2003).
Lumenal cell seeding and proliferation on PLLA tubes using dynamic
Couette-Taylor bioreactors. ETES. 31.
Curran
SJ, Chen R, Hunt JM, Williams DF.
(2004). Tissue Engineering
Nascent Cartilage using Surface Modified PLLA Mircospheres in an Intermittent
Stirred-Flow Bioreactor. 7th
World Congress on Biomaterials, Sydney, Australia. May. 32.
Dallas
SL, Jones CM, Barley C, Peters DM, Mosher DF, Bonewald LF, Humphries MJ and
Kielty CM. (2001). Fibronectin is required for efficient assembly of latent TGFβ binding
protein-1 into the extracellular matrix.
Int. Association for Dental Research (IADR) Meeting. 33.
Diagne
I, Hall SM, Kogake S, Kielty CM, Haworth SG.
(2001). Activity of paxillin
helps drive postnatal pulmonary arterial
remodelling. Cardiology in the
Young, 11:2. 34.
Donegan
G, Hunt JA, Rhodes NP and Williams DF.
(2003). The role of
extracellular matrix in the hybrid tissue engineered vascular construct. 18th Conference on Biomaterials,
Stuttgart, October. 35.
Feugier,
P, Black, RA, Hunt, JA and How, TV.
(2002). Surface configuration
determines adherence and behaviour of endothelial cells seeded on vascular
prosthesis materials subjected to shear stress. 2nd European Symposium of Vascular Biomaterials,
Hamburg, Germany, 31st November. 36.
Fletcher,
JL, Ball, SG & Kielty, CM (2003) Selection of human vascular progenitor
cells from bone marrow, and differentiation into smooth muscle-like cells.
International Tissue Engineering meeting, Hilton Head, SC, USA
(February/March). 37.
Freeman
L, Mellody KM, Shuttleworth CA and Kielty CM.
(2002). Fibrillin degradation by
matrix metalloproteinases: further characterisation of cleavage sites in
fibrillin-1 molecules and is assembled microfibrils. Abstract at Elastin 2002 Symposium, Italy. July. 38.
Freeman
L, Rock MJ, Mellody K, Bax DV, Shuttleworth CA, Kogake S, Hall S, Haworth SG
and Kielty CM. (2003). Fibrillin-1 interactions with elastic fibre
molecules. BSMB, Oxford, UK. March/April. 39.
Freemont
AJ, Hoyland JA, Rajpura A, Byers RJ, Bartley C, Jeriorska M, Knight M, Ross R,
O’Brien J, Sutcliffe J, Le Maitre CL.
(2001). Matrix degradation by
chondrocytes in the intervertebral disc is mediated by Interleukin. British Society for Rheumatology Annual
General Meeting. 24th-27th
April. 40.
Fujiyoshi
KJA, Hunt JA. (2003). The effects of metal ions and dental
endodontic sealant on the regulation of CXCR1, CXCR2 and CD11b
expressions. 18th European
Society for Biomaterials. Stuttgart,
October. 41.
Ghosh,
J, Walker, MG & Kielty, CM (2003) Expression of extracellular matrix and cytoskeletal
molecules by vascular smooth muscle cells under shear stress. European Tissue
Engineering Society (ETES) meeting, Italy, August. 42.
Grieve
FM, Jones CJ, Le Maitre CL, Staley WA, Hoyland JA, Byers RJ. (2001).
Chondrogenic transdifferentiation during osteoblastic differentiation of
marrow stromal cells. J.Pathol. 195,
10A. 43.
Grieve F. Jones CJ, Le Maitre CL, Staley WA, Hoyland JA,
Byers RJ. (2002).
Chondrogenic transdifferentiation during osteoblastic differentiation of
marrow stromal cells. Bone. 30, C14. 44.
Halford
B, Sutcliffe CJ, Morgan RH, Callaghan J, Hunt JA, Black RA. (2001).
Development of a process for the manufacture of high performance
cementless orthopaedic prostheses with a novel biomaterial structure. Time Compression Technologies, Manchester,
25th-26th September. 45.
Hundal
K, Watkins A, Le Maitre CL, Freemont AJ, Hoyland JA. (2002). Chondrocyte
senescence in intervertebral disc degeneration. J.Pathol. 198, 51A. 46.
Hunt
JA, Cooper JJ. (2004). HA-PLLA and PLLA interference screws in ACL
reconstruction: in vivo model to study the tissue response. Arthroscopy Association of North
America. April. 47.
Jackson
P, Hunt JA, Knight J. (2001). Effect of Controlled Release Glass (C.R.G.)
chemistry and particulate size on the neutrophil’s respiratory burst. ESB, London, 12-14th September. 48.
Jackson,
PV, Hunt, JA, Doherty,PJ, Mobasheri, A, Cannon, AM, and Gilson, P. (2003).
Cartilage Tissue Engineering: Culture Methods, Material Geometry and
Chondrocyte Models. Accepted to the
American Society for Biomaterials Meeting. 49.
Jackson
PV, Hunt JA, Doherty PJ, Cannon A, Gilson P.
(2003). Hydrophilicity of 3-D
biomaterials: The Washburn Equation. 18th
European Society for Biomaterials.
Stuttgart, October. 50.
Johnston,
K, Lomas, A, Heagerty, AM, Kielty, CM (2002) Characterising vascular smooth
muscle cells for use in small diameter grafts. In 'Towards Biofunctional
Cardiovascular Implants' ISACB meeting (St Gallen, Switzerland), Feb-Mar. 51.
Johnston,
K, Lomas, A, Stephan, S, Sinha, S, Shuttleworth, CA & Kielty, CM (2002)
Human smooth muscle cell phenotypic modulation by extracellular matrix I:
collagen VIII. Abstract and poster at Federation of European Connective Tissue
Societies (FECTS) meeting, Brighton July. 52.
Khassaf
M, Hunt JA, Flanagan B. (2003). The inflammatory response to metal surfaces
by a human peripheral blood lymphocyte-macrophage coculture. 18th European Society for
Biomaterials. Stuttgart, October. 53.
Kielty
CM. (2001). Assembly and molecular organisation of fibrillin-rich
microfibrils. First European Symposium
on Elastin. Reims, France 54.
Kielty
CM, Johnston K, Lomas A. (2002). Characterising vascular smooth muscle cells
for use in small diameter grafts.
Cardiovasc.Pathol. 11, 50. 55.
Le
Maitre CL, Rajpura A, Staley WA, Byers RJ, Ross R, Knight M, Freemont AJ,
Hoyland JA. (2001). In Vitro gene transfer to human
intervertebral disc chondrocytes by an adenovirus vector. J.Pathol. 193, 1A-1A. 56.
Le
Maitre CL, Rajpura A, Staley W, Byers RJ, Ross R, Knight M, Freemont AJ,
Hoyland JA. (2001). In Vitro gene transfer to human
intervertebral disc chondrocytes by an adenovirus vector. Keystone Symposia – Gene Therapy 2001: A
Gene Odyssey. 6th-11th
January. 57.
Le
Maitre CL, Rajpura A, Staley W, Byers RJ, Ross R, Knight M, Freemont AJ,
Hoyland JA. (2001). In Vitro gene transfer to human
intervertebral disc chondrocytes by an adenovirus vector. British Society for Rheumatology Annual
General Meeting, 24th-27th April. 58.
Le
Maitre CL, Rajpura A, Watkins A, Staley W, Ross R. (2002). In Vitro gene
transfer to human intervertebral disc chondrocytes by an adenovirus
vector. ‘Britspine’ 27th
February-1st March. 59.
Le
Maitre CL, Staley W, Williamson B, Ross R, Knight M, Freemont AJ, Hoyland
JA. (2002). Ex vivo gene transfer by an adenovirus vector to cells isolated from
degenerate human intervertebral discs.
International Society for the Study of the Lumbar Spine, 14th-18th
May. 60.
Le
Maitre CL, Williamson B, Ross R, Knight M, Freemont AJ, Hoyland JA. (2002).
In vitro culture system for the maintenance of human intervertebral disc
tissue. International Society for the
Study of the Lumbar Spine, 14th-18th May. 61.
Le
Maitre CL, Williamson B, Ross R, Freemont AJ, Hoyland JA. (2002).
IL-1 in degenerative disc disease.
Pain in the Back, 20th November. 62.
Le
Maitre CL, Williamson B, Ross R, Freemont AJ, Hoyland JA. (2002).
Response of human intervertebral disc cells to IL-1. The Society for Back Pain Research Annual
General Meeting, 14th-15th November. 63.
Le
Maitre CL, Williamson B, Ross R, Freemont AJ, Hoyland JA. (2002).
In Vitro culture system for the maintenance of human intervertebral disc
tissue. The Society for Back Pain
Research Annual General Meeting, 14th-15th November. 64.
Le
Maitre CL, Baird P, Williamson B, Ross R, Freemont AJ, Hoyland JA. (2002).
Expression of the IL-1 family in human intervertebral disc. The Society for Back Pain Research Annual
General Meeting. 14th-15th
November. 65.
Le
Maitre CL, Richardson SMA, Baird P, Williamson B, Ross R, Freemont AJ, Hoyland
JA. (2003). IL-1: Role in degeneration of the intervertebral disc and its
inhibition using IL-1Ra gene transfer.
Molecular Therapy, 7(5), S405. 66.
Le
Maitre CL, Baird P, Williamson B, Ross R, Freemont AJ, Hoyland JA. (2003).
IL-1 in the intervertebral disc – role in degeneration. 1st International Conference on
Cytokine Medicine. 27th-28th February. 67.
Le
Maitre CL, Williamson B, Ross R, Freemont AJ, Hoyland JA. (2003).
Response of human intervertebral disc cells to IL-1. British Society for Rheumatology Annual
General Meeting. 2nd-4th
April 68.
Le Maitre
CL, Baird P, Williamson B, Ross R, Freemont AJ, Hoyland JA. (2003).
Expression of the IL-1 family in human intervertebral disc. British Society for Rheumatology Annual
General Meeting. 2nd-4th
April. 69.
Le
Maitre CL, Williamson B, Ross R, Freemont AJ, Hoyland JA. (2003).
Culture system for the maintenance of human intervertebral disc
tissue. British Society for
Rheumatology Annual General Meeting. 2nd-4th
April. 70.
Le
Maitre CL, Williamson B, Ross R, Freemont AJ, Hoyland JA. (2003).
Response of human intervertebral disc cells to IL-1. International Society for the Study of the
Lumbar Spine. 13th-17th
May. 71.
Le
Maitre CL, Baird P, Williamson B, Ross R, Freemont AJ, Hoyland JA. (2003).
Expression of the IL-1 family in human intervertebral disc. International Society for the Study of the
Lumbar Spine. 13th-17th
May. 72.
Lee
DM, Rock MJ, Shuttleworth CA, Kielty CM (2001). In vitro assembly of recombinant fibrillin-1. Int.J.Exptl.Pathol. 82, A11-A12. 73.
Lee
DM, Lomas A, Kielty CM. (2002). Evaluation of adult mesenchymal stem cells
as a possible source of vascular smooth muscle cells in small diameter
grafts. Cardiovasc.Pathol. 11, 50. 74.
Lee,
DM, Lomas, A, Kielty, CM. (2002). Evaluation of adult human mesenchymal stem
cells as a possible source of vascular smooth muscle cells in small diameter
grafts. Abstract at 'Towards Biofunctional Cardiovascular Implants' ISACB
meeting (St Gallen, Switzerland), Feb-Mar. 75.
Lomas,
A, Bernard, SE, Shuttleworth, CA & Kielty, CM (2002) Influence of elastic
fibre components on smooth muscle cell phenotype. Abstract and poster at
Federation of European Connective Tissue Societies (FECTS) meeting, Brighton
July. 76.
Lomas,
AC, Ball, SG & Kielty, CM (2003) Molecular studies in vascular graft
design. BSMB, Oxford March/April. 77.
Longinotti C, Tognana E, Srivastava J, De Luca C, Piccolo
F and Rhodes NP. (2003). Mesenchymal stem cells seeded HYAFF-based scaffolds for ligament
reconstruction: effect of culture conditions.
2nd Annual Meeting of the European Tissue Engineering
Society, Genova. 78.
Markkula
TK, Pu F, Hunt JA, Williams RL.
(2001). Effect of plasma
treatment on cell growth on PET and PTFE.
ESB, London, 12th-14th September. 79.
Markkula
TK, White R, Pu F, Hunt JA, Williams RL.
(2001). Surface functional group
analysis of gas plasma modified PET and PTFE.
ESB, London, 12th-14th September. 80.
Mellody
KM, Baldock C, Shuttleworth CA and Kielty CM.
(2002). Recombinant expression
and analysis of fibrillin-1 proline-rich region and fibrillin-2 glycine-rich
region. Abstract and poster at
Federation of European Connective Tissue Societies (FECTS) Meeting, Brighton,
UK. July. 81.
Metcalfe
AD, Willis HS, Rajnoch C, Ferguson S and Ferguson MWJ. (2003).
Regeneration of the ear following wounding in different mouse strains is
dependent on the severity of wound trauma.
Gordon Research Conference, Barga, Italy. 82.
Metcalfe
AD, Willis HS, Rajnoch C, Ferguson S and Ferguson MWJ. (2003).
Ear regeneration following wounding in 3 mouse strains is dependent on
the severity of wound trauma. European
Tissue Repair Society Meeting, Amsterdam. 83.
Murdoch
AD, Oldershaw RA, Hardingham TE.
(2003). Differential regulation
of cell-surface proteoglycans by chondrocytes during adaptation to cell
culture. 49th Annual Meeting
of the Orthopaedic Research Society. 2nd-5th
February, New Orleans, LA, USA. Podium
Presentation. 84.
Murdoch
AD, Oldershaw RA, Hardingham TE.
(2003). Expansion in FGF-2
promotes matrix synthesis during chondrogenic differentiation of human bone
marrow mesenchymal cells without upregulating SOX9. Tissue and Cell Engineering Society Meeting, 8th-10th
September, Cardiff, UK. Podium
Presentation. 85.
Murdoch
AD, Oldershaw RA, Hardingham TE (2003).
Expansion in FGF-2 promotes matrix synthesis during chondrogenic
differentiation of human bone marrow mesenchymal cells without upregulating
SOX9. Tissue Engineering Society
International, 6th Annual International Conference, 10th-13th
December, Orlando, Florida, USA. Podium
Presentation. 86.
Murdoch
AD, Oldershaw RA, Hardingham TE.
(2004). Expansion in FGF-2
promotes matrix synthesis during chondrogenic differentiation of human bone
marrow mesenchymal cells without upregulating SOX9. 50th Annual Meeting of the Orthopaedic Research
Society, 7th-10th March, San Francisco, CA, USA. Selected for poster presentation. 87.
Murray,
D, Russell, A, Walker, MG & Kielty, CM (2003) The effects of growth factors
on smooth muscle cell expression of extracellular matrix. International Tissue
Engineering meeting, Hilton Head, SC, USA (February/March). 88.
Murray,
D, Russell, A., Ghosh, J, Walker, M. G., & Kielty, C. M. (2003) Adenoviral
mediated delivery of TGF-β1 into human coronary artery smooth muscle cells promotes deposition of
extracellular matrix. Italy meeting, September. 89.
Phillips
S, Shuttleworth CA and Kielty CM.
(2002). Fate of intracellular
fibrillin-1. Abstract and poster at
Federation of European Connective Tissue Societies (FECTS) Meeting, Brighton,
UK. July. 90.
Pu
F, Williams RL, Markkula TK, Hunt JA.
(2001). Effects of gas plasma
treated PET and PTFE on expression of adhesion molecule on human artery
endothelial cells (HCAECs) in vitro.
ESB, London, 12th-14th September. 91.
Pu
F, Williams RL, Markkula TK, Hunt JA.
(2001). Monocyte adhesion and
adhesion molecule expression on human endothelial cells on plasma treated PET
and PTFE in vitro. ESB, London, 12th-14th
September. 92.
Pugh
GE, Shuttleworth CA, Kielty CM.
(2001). A-domain interactions in
collagen VI assembly.
Int.J.Exptl.Pathol. A15-A16. 93.
Rajnoch,
C, Ferguson, S. Metcalfe, AD, Herrick, SE, Willis, HS, and Ferguson, MJW. (2002).
Regeneration of the ear following wounding in different mouse strains in dependent on the severity
of wound trauma. Euresco International
Conference on Regeneration, Lucca, Italy, 1st-5th
September. 94.
Rajnoch
C, Metcalfe AD, Willis HS, Ferguson S, Herrick SE and Ferguson MWJ. (2002).
Mechanisms of ear regeneration following wounding in different mouse
strains. Euresco Conference, Lucca,
Italy. 95.
Rhodes
NP, Longinotti C and Srivastava JK.
(2003). Heterogeneity in proliferative
potential of ovine mesenchymal stem cell colonies. 18th Conference on Biomaterials. Stuttgart. 96.
Rhodes
NP, Longinotti C and Srivastava JK.
(2003). Metabolic and
histological analysis of mesenchymal stem cells grown on hyaluronan-based substrates. 18th Conference on Biomaterials,
Stuttgart. 97.
Rice
JM, Chen R, Hunt JA, Rhodes NP, Black RA, Williams DF. (2003).
Control of human mesenchymal stem cell adherence, proliferation and
differentiation via different chemically functionalised surfaces. TESi, December 98.
Rice
JM, Hunt JA, Gallagher JA, Hanarp P, Gold J.
(2001). The response of primary
unstimulated human cells to a range of chemically homogenous nanotopography
surfaces in vitro. ESB, London 12th-14th
September. 99.
Rice
JM, Hunt JA, Gallagher JA, Smith NG.
(2001). Assessment of the
potential biocompatible and osteogenic properties of a range of BCP granules in
vitro. ESB, London, 12th-14th
September. 100.
Richardson
S, Watkins A, Hoyland JA, Le Maitre CL, Baird P, Ross R, Williamson B, Freemont
AJ. (2002). Expression of growth factor receptors within the diseased and
normal intervertebral disc. The Society
for Back Pain Research Annual General Meeting, 14th-15th
November. 101.
Richardson
S, Le Maitre CL, Hoyland JA, Freemont AJ.
(2003) Poster presentation –
Localisation of cytokine receptor expression in normal and diseased
intervertebral disc. 1st
International Conference on Cytokine Medicine.
27th-28th February. 102.
Richardson
S, Le Maitre CL, Russell A, Greenway E, Li Y, Freemont AJ, Hoyland JA. (2003).
Human bone marrow mesenchymal stromal cells as a source of chondrocytes
for treatment of intervertebral disc degeneration. International Society for the Study of the Lumbar Spine. 13th-17th May. 103.
Richardson
S, Le Maitre CL, Russell A, Greenway E, Li Y, Freemont AJ, Hoyland JA. (2003).
Human bone marrow mesenchymal stromal cells as a source of chondrocytes
for treatment of intervertebral disc degeneration. Tissue and Cell Engineering Society. 9th-10th September. 104.
Rock
MJ, Lee DM, Shuttleworth CA and Kielty CM.
(2001) Assembly of recombinant
full-length and minigene fibrillin-1.
Abstract, British Society for Matrix Biology Meeting, April. 105.
Rock
MJ, Shuttleworth CA and Kielty CM.
(2002). Recombinant expression
of a fibrillin-1 minigene. Abstract at
Elastin 2002 Symposium, Italy. July. 106.
Rock
MJ, Shuttleworth CA and Kielty CM.
(2002). Recombinant expression
of a fibrillin-1 minigene. Abstract,
poster and workshop presentation at Federation of European Connective Tissue
Societies (FECTS) Meeting, Brighton, UK.
July. 107.
Rock
MJ, Mellody K, Merson A, Shuttleworth CA and Kielty CM. (2003).
Interaction studies of recombinant fibrillin-1. BSMB, Oxford, UK. March/April 108.
Rock
MJ, Mellody K, Freeman L, Shuttleworth
CA and Kielty CM. (2003). Fibrillin-1 interactions in microfibril
assembly. Gordon Research Conference
‘Elastin and Elastic Fibres’, August. 109.
Sherratt
MJ, Baldock C, Haston JL, Holmes DF, Jones CJP, Shuttleworth CA, Wess TJ and
Kielty CM. (2003). Determining Young’s modulus for an isolated
supra-molecular assembly. NESBIC
Meeting, June. 110.
Sherratt,
MJ, Holmes, DF, Shuttleworth, CA & Kielty, CM (2003) Fibrillin microfibrils
are stiff reinforcing fibres in compliant tissues. Gordon Research Conference
‘Elastin and Elastic fibres’, August. 111.
Sive JI, Baird P, Le Maitre CL, Hoyland JA, Freemont
AJ. (2001).
Investigation into the chondrocyte phenotype and pattern of aggrecan
distribution in cells of the normal and degenerate intervertebral disc. J.Pathol. 195, 37A-37A. 112.
Stephan,
S, Shuttleworth, CA & Kielty, CM (2002) Recombinant expression and
supramolecular assembly of human collagen VIII. Abstract and poster at
Federation of European Connective Tissue Societies (FECTS) meeting,
Brighton. July. 113.
Tang
ZG, Black RA, Rice JM, Hunt JA, Rhodes NP and Williams DF. (2003). Differential cellular responses to poly
(ε-caprolactone) films: effect of solvent-induced variations in surface
microstructure. 2nd Annual
Meeting of the European Tissue Engineering Society, Genoa, Italy, 1st-4th
September. 114.
Tang
ZG, Black RA, Rice JM, Hunt JA, Rhodes NP, Williams DF. (2003).
Fabrication-induced surface properties of the poly (ε-caprolactone)
film and the effects on adhesion and proliferation of fibroblasts. 18th European Society for
Biomaterials, Stuttgart, October. 115.
Tang
ZG, Black RA, Curran JM, Williams DF, Metcalfe AD, Ferguson MWJ. (2004).
Controlled TGF-β3 Release from Porous Poly(e-caprolactone)
Carriers. 7th World Congress
on Biomaterials, Sydney Australia. 116.
Tew
SR, Prince JM, Hawkins R and Hardingham TE.
(2002). Enhanced chondrocyte
re-differentiation after SOX9 transduction,
XVIIIth FECTS meeting, Brighton, UK July. 117.
Tew,
SR, Li, Y, Russell, AM, Prince, JM, Hawkins, RE and Hardingham, TE.
(2002). The re-expression of
chondrocyte phenotype by passaged human articular chondrocytes is improved by
viral transduction of SOX9. Tissue and Cell Engineering Society Meeting,
Glasgow, UK. 19th-20th
September. 118.
Tew,
SR, Li, Y, Russell, AM, Prince, JM, Hawkins, RE and Hardingham, TE.
(2002). Enhanced chondrocyte redifferentiation
after SOX9 transduction. 3rd
Smith & Nephew International Symposium, Atlanta, Georgia, USA. 13th-16th
October. 119.
Tew,
SR, Li, Y, Russell, AM, Prince, JM, Hawkins, RE and Hardingham, TE.
(2003). Retroviral SOX9 transduction
improves re-expression of type II collagen by passaged human articular
chondrocytes in 3-dimensional culture.
49th Annual Meeting of the Orthopaedic Research Society, 2nd-5th
February, New Orleans, LA, USA. 120.
Tew,
SR, Li, Y, Katopodi, T, Murdoch, AD, Hawkins, RE and Hardingham, TE.
(2003). SOX9 overexpression in human
articular chondrocytes regulates glycosaminoglycan synthetic capacity and mRNA
expression of linkage region glycosyltransferases. British Society for Matrix Biology, Spring Meeting, Oxford, UK.
31st March-1st April. 121.
Tew
SR, Li Y, Tweats LM, Katopodi T, Hawkins RE, Hardingham TE. (2003).
SOX9 transduction and TGFβ-3 treatment of late passage human
articular chondrocytes in pellet culture potentiates cartilage matrix
formation. Tissue and Cell Engineering
Society Meeting, 8th-10th September, Cardiff, UK. 122.
Tew
SR, Katopodi T, Li Y, Hawkins RE, Murdoch AD, Hardingham TE. (2004).
Retroviral SOX9 transduction
upregulates glycosyltransferases of glycosaminoglycan synthesis in passaged human
articular chondrocytes. 50th
Annual Meeting of the Orthopaedic Research Society, 7th-10th
March, San Francisco, CA, USA.. 123.
Turner
N, Kielty C, Walker MG & Canfield A.
(2002). “A Novel Hyaluronic Acid
Biomaterial (Hyaff-11) as a Scaffold for Endothelial Cells in Tissue Engineered
Vascular Grafts” Healthcare Science
Week, November. MRI. 124.
Turner,
N, Kielty, CM, Walker, MG & Canfield, AE (2003) A Novel Hyaluronan
Biomaterial (Hyaff-11) as a Scaffold for Endothelial Cells in Tissue Engineered
Vascular Grafts. International Tissue Engineering meeting, Hilton Head, SC, USA
(February/March). 125.
Turner
N, Kielty CM, Walker MG, Canfield AE.
(2003). A Novel Hyaluronan
Biomaterial (Hyaff-11) as a Scaffold for Endothelial Cells in Tissue
Engineering Vascular Grafts. Tissue
Engineering Blood Vessels Conference, Gothenburg, Sweden, April. 126.
Turner
N, Kielty CM, Walker MG, Canfield AE.
(2003). Analysis of Endothelial
Attachment to a Hyaluronan Based Biomaterial (Hyaff-11®) and Recombinant Type
VIII Collagen. Tissue Engineering
Society International Conference, Orlando, USA. December. |